Pharmaceutical-Grade BAC Water | Houston, TX | HPLC-Tested | COA Every Order
HPLC Testing in Compounding Pharmacies | USP 797, 503A & 503B Standards
For compounding pharmacies, the quality documentation requirements on incoming pharmaceutical components are not aspirational guidelines — they are regulatory mandates. Whether you operate a 503A traditional compounding pharmacy or a 503B outsourcing facility, bacteriostatic water used in sterile compounding must be sourced, documented, and verified to a standard that survives FDA and state board inspection. HPLC purity testing is a central component of that verification standard. This guide explains what HPLC documentation compounding pharmacies should require from their BAC water suppliers, how it maps to regulatory expectations, and what complete documentation looks like.
The Regulatory Framework for Sterile Compounding
USP Chapter 797
USP 797 (Pharmaceutical Compounding — Sterile Preparations) is the primary standard governing sterile compounding in the United States. It covers facilities, personnel, procedures, testing, and documentation requirements for all sterile compounded preparations. Key provisions relevant to BAC water sourcing include:
- All components used in sterile compounding must be of appropriate quality — from a licensed pharmaceutical supplier with a current COA
- Component identity verification is required before use
- Sterility and endotoxin testing requirements for finished preparations (which depend partly on the sterility status of incoming components)
- Beyond-use date (BUD) assignment based on risk level and preparation conditions
503A vs 503B: The Documentation Difference
| Requirement | 503A (Traditional Compounding) | 503B (Outsourcing Facility) |
|---|---|---|
| Primary Regulator | State Board of Pharmacy | FDA (plus State Board) |
| cGMP Requirements | USP 797 compliance | Full pharmaceutical cGMP (21 CFR 211) |
| Component COA Requirement | Required — identity and quality documentation | Required — must meet pharmaceutical grade specifications |
| HPLC Documentation | Strongly recommended — supports component identity verification | Required — HPLC purity data is standard for pharmaceutical component certification |
| Endotoxin Documentation | Required for sterile compounding components | Required — numerical results, not just pass/fail |
| Batch Traceability | Required — lot/batch number recorded | Required — full batch record traceability |
| Supplier Qualification | Licensed supplier with adequate COA | Approved vendor program with qualification documentation |
What HPLC Documentation Compounding Pharmacies Should Require
When sourcing bacteriostatic water for sterile compounding, a compliant HPLC COA should include:
- Test Method Reference — specific HPLC method used (column type, mobile phase, detection wavelength, flow rate)
- Benzyl Alcohol Concentration — result must fall within 0.88–0.92% (8.8–9.2 mg/mL) per USP specification
- Overall Purity — percentage of total chromatographic area attributed to benzyl alcohol peak (target: NLT 98.0%)
- Impurity Peaks — any secondary peaks above reporting threshold (typically 0.1%) must be identified or characterized
- Acceptance Criteria — the specification that was tested against, not just the result
- Pass/Fail Conclusion — explicit statement of compliance
- Batch Number — linking the COA to the specific manufactured batch
- Analyst Signature and Date — traceability to the individual who performed the analysis
Endotoxin Testing: The Equal Partner to HPLC in Sterile Compounding
For sterile compounding, endotoxin testing of incoming components is as critical as HPLC purity testing. Bacteriostatic water used in sterile preparations must have documented endotoxin levels — a COA that shows only HPLC purity but no endotoxin data is insufficient for USP 797 compliance. LAL (Limulus Amebocyte Lysate) endotoxin testing should be documented with:
- Numerical result (EU/mL) — not just “pass” or “complies”
- Test method (gel-clot, turbidimetric, or chromogenic LAL)
- Acceptance criteria (typically <0.5 EU/mL for pharmaceutical injection components; research grade targets <0.1 EU/mL)
- Batch correlation to the HPLC data
Inspections: What Auditors Look For in BAC Water Documentation
During FDA inspections of 503B facilities and state board inspections of 503A pharmacies, auditors reviewing sterile compounding operations typically examine:
- Current, batch-specific COA for all sterile components in use on the compounding floor
- Evidence of identity verification — confirming the component received matches the labeled material
- Endotoxin data — numerical results, not just a statement of compliance
- Supplier qualification documentation — evidence the supplier has been evaluated and approved
- Chain of custody — documentation linking the specific batch in use to its COA and receiving records
Renew Lab Group’s batch-level COA documentation is designed to support this audit trail. Each COA is specific to the manufactured batch (identified by batch number), documents HPLC purity with method reference, LAL endotoxin with numerical result, benzyl alcohol concentration, pH, and sterility status — everything an auditor would expect to see for a sterile compounding component.
Supplier Qualification for Compounding Pharmacies
503B outsourcing facilities and many sophisticated 503A pharmacies maintain a qualified vendor program. To add Renew Lab Group to your approved vendor list, you typically need:
- Current COA for the specific product SKU you plan to purchase
- Supplier questionnaire completion (manufacturing site, QA system, testing capabilities)
- Proof of manufacturing in an appropriate facility (ISO cleanroom documentation)
- Evidence of testing capabilities (HPLC, LAL, USP 71 sterility)
Contact our team for supplier qualification support documentation. We provide complete documentation packages for compounding pharmacy vendor qualification.
FAQs — HPLC and Compounding
Does USP 797 require HPLC testing of bacteriostatic water specifically?
USP 797 requires that components used in sterile compounding be of appropriate quality with adequate documentation. For a pharmaceutical component like bacteriostatic water, appropriate documentation includes HPLC purity verification, endotoxin testing, sterility documentation, and component identity confirmation. While HPLC testing of BAC water specifically is not called out by name in USP 797 text, it is the standard method for meeting the purity documentation requirement for this component type.
Can a 503A pharmacy use our BAC water for sterile compounding?
Yes. Our bacteriostatic water comes with HPLC purity documentation, LAL endotoxin data, USP 71 sterility confirmation, benzyl alcohol concentration, and pH — all the documentation elements that support 503A compounding pharmacy compliance requirements. Contact us for our supplier qualification package.
What makes Renew Lab Group different from other BAC water suppliers for compounding?
The key differentiator is batch-level documentation. Many BAC water suppliers provide lot-level COAs — a single document covering a large production lot that may span many individual batches. Our COAs are batch-specific: they document the exact manufactured batch that generated your product, with HPLC purity, endotoxin, benzyl alcohol, pH, and sterility all tied to that specific batch number. This batch-level traceability is what sophisticated compounding operations and their inspectors expect.
Related: What Is HPLC Testing? | What Is Endotoxin? | Certificate of Analysis | Compounding Pharmacy Hub
Compounding Pharmacy Accounts — Wholesale Pricing Available
Batch-level HPLC + endotoxin documentation. Supplier qualification support. Contact our team.
⚗️ For Research Use Only. Not intended for human or veterinary use. This content is for educational and informational purposes only and does not constitute regulatory or legal advice.
